Market Update (NYSE:AGN): Allergan Issues Statement Regarding Recent Valeant Correspondence

[Business Wire] – Allergan, Inc. today issued a statement regarding recent correspondence between Allergan and Valeant Pharmaceuticals International, Inc. ( Read more on this. Allergan Inc. (AGN), currently valued at $52.35B, started . . . → Read More: Market Update (NYSE:AGN): Allergan Issues Statement Regarding Recent Valeant Correspondence Similar Articles: Market Update (NYSE:AGN): Pershing Square, Valeant and Allergan Settle Pending Litigation Before the Delaware Court of Chancery Company Update (NYSE:AGN): Allergan Provides Update on Written Requests from Pershing Square Regarding Special Meeting of Stockholders Stock Update (NYSE:AGN): Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Now Approved in the European Union for the Treatment of Diabetic Macular Edema